Brief: UK High Court Rules In Favor Of Alvotech Paving Way For AVT06, Biosimilar To Eylea
10/11/2025 11:45
Nov 10 (Reuters) - Alvotech SA ALVO.O: UK HIGH COURT RULES IN FAVOR OF ALVOTECH PAVING WAY FOR MANUFACTURE AND MARKET ENTRY OF AVT06, BIOSIMILAR TO EYLEA® (AFLIBERCEPT) ALVOTECH SA - UK HIGH COURT RULES IN FAVOR OF ALVOTECH AGAINST REGENERON AND BAYER Source text: ID:nGNX1NcPnd Further company coverage: ALVO.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Alvotech SA
See all newsBrief: CMS Announces Selection Of Drugs For Third Cycle Of The Medicare Drug Price Negotiation Program
Brief: Alvotech and Teva Secure U.S. Settlement Date For AVT06
India's Dr Reddy's rises after EU marketing authorisation for osteoporosis biosimilar
Brief: UK High Court Rules In Favor Of Alvotech Paving Way For AVT06, Biosimilar To Eylea
U.S. STOCKS ON THE MOVE-Cummins, EPAM Systems, Qualcomm